Julphar Julphar is one of the largest pharmaceutical manufacturers in the MEA region. The Julphar story is one of innovation and leadership.
(1)

Since our journey began in 1980, our goal has remained the same – to bring better healthcare and a brighter future to families across the globe. And in less than 40 years, we have expanded our network across the Middle East and Africa to become one of the largest pharmaceutical manufacturers in the region. Headquartered in Ras Al Khaimah in the United Arab Emirates, we employ 3,400 people, and we market our products in more than 30 countries. We have 12 internationally accredited facilities that produce more than half a million medicine boxes a day, including tablets, syrups, suspensions, creams and injectables, and vaccines. Julphar has an extensive portfolio of generic medicines, branded generics, and over-the-counter medicines, as well as APIs (active pharmaceutical ingredients). We develop and manufacture medicines and supplements for everything from the common cold to diabetes.

In World Doctor’s Day, we recognize the brilliance and dedication behind every life changed. Thank you to the doctors wh...
30/03/2026

In World Doctor’s Day, we recognize the brilliance and dedication behind every life changed. Thank you to the doctors who make a difference every single day.

20/03/2026
Today, we celebrate the strength, resilience, and impact of women everywhere.At Julphar, we are proud of the inspiring w...
08/03/2026

Today, we celebrate the strength, resilience, and impact of women everywhere.

At Julphar, we are proud of the inspiring women whose dedication, talent, and commitment continue to make a meaningful difference every day. Their contributions help drive innovation, progress, and the pursuit of a healthier future for communities around the world.

Happy International Women’s Day!

As the blessed month of Ramadan begins, Julphar extends its heartfelt wishes to everyone.May this sacred month bring las...
17/02/2026

As the blessed month of Ramadan begins, Julphar extends its heartfelt wishes to everyone.

May this sacred month bring lasting peace and continued well-being to all. Ramadan Mubarak!

مع حلول شهر رمضان المبارك، تتقدم جلفار بأصدق التهاني وأطيب الأمنيات للجميع

نسأل الله أن يحمل هذا الشهر الفضيل سلامًا دائمًا ودوام العافية للجميع

رمضان مبارك 🌙

جلفار توقع اتفاقية استراتيجية لتوريد الأدوية إلى القطاع العام في موريتانيا في أول شراكة مباشرة من نوعها مع مصنع دوائي إم...
13/02/2026

جلفار توقع اتفاقية استراتيجية لتوريد الأدوية إلى القطاع العام في موريتانيا في أول شراكة مباشرة من نوعها مع مصنع دوائي إماراتي

أعلنت الخليج للصناعات الدوائية – جلفار عن توقيع اتفاقية تعاون استراتيجية مع الشركة المركزية لشراء الأدوية والمستلزمات الطبية في الجمهورية الإسلامية الموريتانية (كامك)، وتُعد هذه الاتفاقية خطوة استراتيجية غير مسبوقة، إذ تمثل الأولى من نوعها في مجال توريد الأدوية إلى القطاع العام الموريتاني عبر شراكة مباشرة مع مصنع دوائي إماراتي، الأمر الذي يعزز التكامل الصحي بين البلدين ويدعم الجهود الوطنية الهادفة إلى تحقيق الأمن الدوائي وضمان استدامة الإمدادات الطبية.

وبموجب الاتفاقية، سيتم العمل على إدماج منتجات جلفار ضمن المنظومة الدوائية الوطنية في موريتانيا، من خلال اعتمادها رسميًا وإدراجها ضمن سلة الأدوية المعتمدة، بما يتيح توافر أدوية عالية الجودة للمستشفيات والمؤسسات الصحية في القطاعين العام والخاص، ويسهم في رفع كفاءة الخدمات العلاجية وتعزيز استقرار السوق الدوائي المحلي.

وتؤكد هذه الخطوة التزام جلفار بتوسيع حضورها الإقليمي وتعزيز دورها كشريك استراتيجي للحكومات في دعم الأنظمة الصحية الوطنية، من خلال توفير حلول دوائية موثوقة تسهم في تحسين جودة الحياة وتعزيز جاهزية القطاع الصحي لمواجهة التحديات المستقبلية.

𝗪𝗲 𝗮𝗿𝗲 𝗽𝗿𝗼𝘂𝗱 𝘁𝗼 𝗮𝗻𝗻𝗼𝘂𝗻𝗰𝗲 𝘁𝗵𝗲 𝗹𝗮𝘂𝗻𝗰𝗵 𝗼𝗳 𝗥𝗶𝘀𝗲𝗸® 𝗣𝗹𝘂𝘀 (𝗢𝗺𝗲𝗽𝗿𝗮𝘇𝗼𝗹𝗲 / 𝗦𝗼𝗱𝗶𝘂𝗺 𝗕𝗶𝗰𝗮𝗿𝗯𝗼𝗻𝗮𝘁𝗲) 𝗶𝗻 𝘁𝗵𝗲 𝗞𝗶𝗻𝗴𝗱𝗼𝗺 𝗼𝗳 𝗦𝗮𝘂𝗱𝗶 𝗔𝗿𝗮𝗯𝗶𝗮.At J...
09/02/2026

𝗪𝗲 𝗮𝗿𝗲 𝗽𝗿𝗼𝘂𝗱 𝘁𝗼 𝗮𝗻𝗻𝗼𝘂𝗻𝗰𝗲 𝘁𝗵𝗲 𝗹𝗮𝘂𝗻𝗰𝗵 𝗼𝗳 𝗥𝗶𝘀𝗲𝗸® 𝗣𝗹𝘂𝘀 (𝗢𝗺𝗲𝗽𝗿𝗮𝘇𝗼𝗹𝗲 / 𝗦𝗼𝗱𝗶𝘂𝗺 𝗕𝗶𝗰𝗮𝗿𝗯𝗼𝗻𝗮𝘁𝗲) 𝗶𝗻 𝘁𝗵𝗲 𝗞𝗶𝗻𝗴𝗱𝗼𝗺 𝗼𝗳 𝗦𝗮𝘂𝗱𝗶 𝗔𝗿𝗮𝗯𝗶𝗮.

At Julphar, we recognize our responsibility as a key healthcare partner in Saudi Arabia, therefore, this launch marks an important milestone in our commitment to advancing gastroenterology care and improving patient outcomes across the Kingdom.

𝗥𝗶𝘀𝗲𝗸® Plus is designed to deliver reliable acid suppression, addressing key clinical challenges in GERD and related conditions. Its introduction adds meaningful value across the healthcare ecosystem.

As part of this launch, three scientific symposia were successfully held across the Kingdom, led by eminent experts in the field of gastroenterology. These scientific gatherings brought together healthcare professionals to:

- Discuss unmet needs in acid-related disorders.
- Review the scientific rationale behind Omeprazole–Sodium Bicarbonate combinations.
- Share real-world clinical experience and best practices.
- Reinforce evidence-based, patient-centric treatment decisions.

The launch of 𝗥𝗶𝘀𝗲𝗸® Plus reflects our ongoing dedication to science, partnership, and patient care — and it is only the beginning of what we aim to deliver to the Saudi healthcare community.

𝗢𝗻𝗲 𝗧𝗲𝗮𝗺, 𝗢𝗻𝗲 𝗗𝗶𝗿𝗲𝗰𝘁𝗶𝗼𝗻: 𝗝𝘂𝗹𝗽𝗵𝗮𝗿 𝗞𝗦𝗔 𝗖𝘆𝗰𝗹𝗲 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝟮𝟬𝟮𝟲It was a valuable opportunity to connect, align, and strengthen c...
13/01/2026

𝗢𝗻𝗲 𝗧𝗲𝗮𝗺, 𝗢𝗻𝗲 𝗗𝗶𝗿𝗲𝗰𝘁𝗶𝗼𝗻: 𝗝𝘂𝗹𝗽𝗵𝗮𝗿 𝗞𝗦𝗔 𝗖𝘆𝗰𝗹𝗲 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝟮𝟬𝟮𝟲

It was a valuable opportunity to connect, align, and strengthen collaboration across teams — all within an inspiring setting that reflects both heritage and forward momentum.

When we come together, we reaffirm that real success is built on people, purpose, and our shared commitment. With renewed energy and focus, we move ahead ready to build on our achievements and embrace the year ahead.

Thank you to everyone who contributed to making this cycle meeting meaningful and memorable.

Gulf Pharmaceutical Industries - Julphar, congratulates you on the New Year, wishing you and your family a happy year fi...
31/12/2025

Gulf Pharmaceutical Industries - Julphar, congratulates you on the New Year, wishing you and your family a happy year filled with wonderful opportunities and success.

‎تهنئكم شركة الخليج للصناعات الدوائية - جلفار، بالعام الجديد، مع تمنياتنا لكم ولعائلاتكم عامًا سعيدًا مليئًا بالفرص العظيمة والنجاحات الرائعة.

At Julphar Egypt, our recent Cycle Meeting was not just a look back at results, it was a decision about the future we wa...
11/12/2025

At Julphar Egypt, our recent Cycle Meeting was not just a look back at results, it was a decision about the future we want to create together.

We aligned on a sharper path for 2026 and beyond: where we will play, how we will win, how we will accelerate strategic launches, and how we will deepen our impact for patients, partners, and healthcare professionals. But the real strategy shift is inside choosing a growth mindset as our way of working, leading, and collaborating.

Our Cultural Transformation Journey in Egypt is no longer a concept; it’s visible in the courage to try new things, the ownership of results, the way teams support each other, and the belief that we can always raise the bar.

Proud of our Egypt team, proud of the ambition and even more proud of the people bringing “The Future Is Now” to life, one decision at a time. Onwards.

𝗪𝗲 𝘄𝗲𝗿𝗲 𝗽𝗿𝗼𝘂𝗱 𝘁𝗼 𝘁𝗮𝗸𝗲 𝗽𝗮𝗿𝘁 𝗶𝗻 𝘁𝗵𝗲 𝟭𝘀𝘁 𝗔𝗻𝗻𝘂𝗮𝗹 𝗡𝗲𝘂𝗿𝗼𝗹𝗼𝗴𝘆 𝗙𝗼𝗿𝘂𝗺 𝗳𝗼𝗿 𝗟𝗶𝗯𝘆𝗮 𝗡𝗲𝘂𝗿𝗼𝗹𝗼𝗴𝗶𝘀𝘁𝘀 𝗶𝗻 𝗖𝗮𝗶𝗿𝗼The event brought together 1...
10/12/2025

𝗪𝗲 𝘄𝗲𝗿𝗲 𝗽𝗿𝗼𝘂𝗱 𝘁𝗼 𝘁𝗮𝗸𝗲 𝗽𝗮𝗿𝘁 𝗶𝗻 𝘁𝗵𝗲 𝟭𝘀𝘁 𝗔𝗻𝗻𝘂𝗮𝗹 𝗡𝗲𝘂𝗿𝗼𝗹𝗼𝗴𝘆 𝗙𝗼𝗿𝘂𝗺 𝗳𝗼𝗿 𝗟𝗶𝗯𝘆𝗮 𝗡𝗲𝘂𝗿𝗼𝗹𝗼𝗴𝗶𝘀𝘁𝘀 𝗶𝗻 𝗖𝗮𝗶𝗿𝗼

The event brought together 10 leading neurologist key opinion Leaders, marking an important platform for scientific exchange and collaborative advancement in the field of neurology.

We were honored to have Dr. Maged Abdel Naseer, former Head of the Neurology Department at Cairo University, lead the scientific session with an insightful presentation on personalized approaches in the management of Multiple Sclerosis, highlighting the latest updates and evidence-based practices.

This forum offered a valuable opportunity to exchange expertise, strengthen regional collaboration, and keep neurologists updated with the latest scientific insights that directly support better patient care.

𝗝𝘂𝗹𝗽𝗵𝗮𝗿 𝗶𝘀 𝗽𝗿𝗼𝘂𝗱 𝘁𝗼 𝗮𝗻𝗻𝗼𝘂𝗻𝗰𝗲 𝘁𝗵𝗲 𝘀𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹 𝗰𝗼𝗺𝗽𝗹𝗲𝘁𝗶𝗼𝗻 𝗼𝗳 𝘁𝗵𝗲 𝘁𝗵𝗶𝗿𝗱 𝗮𝗻𝗱 𝗳𝗶𝗻𝗮𝗹 𝗰𝗼𝗵𝗼𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗙𝗟𝗟 𝟮𝟬𝟮𝟱 𝗽𝗿𝗼𝗴𝗿𝗮𝗺.This milest...
03/12/2025

𝗝𝘂𝗹𝗽𝗵𝗮𝗿 𝗶𝘀 𝗽𝗿𝗼𝘂𝗱 𝘁𝗼 𝗮𝗻𝗻𝗼𝘂𝗻𝗰𝗲 𝘁𝗵𝗲 𝘀𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹 𝗰𝗼𝗺𝗽𝗹𝗲𝘁𝗶𝗼𝗻 𝗼𝗳 𝘁𝗵𝗲 𝘁𝗵𝗶𝗿𝗱 𝗮𝗻𝗱 𝗳𝗶𝗻𝗮𝗹 𝗰𝗼𝗵𝗼𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗙𝗟𝗟 𝟮𝟬𝟮𝟱 𝗽𝗿𝗼𝗴𝗿𝗮𝗺.

This milestone underscores our ongoing commitment to developing leadership capabilities, fostering a culture of continuous growth, and promoting accountability and excellence throughout the organization.

We sincerely thank all participants for their dedication and active engagement during the program. We also extend our gratitude to the leadership team and supporting departments, whose guidance and collaboration made this initiative possible.

Together, we continue to invest in building strong leaders who will shape Julphar’s future with purpose and impact.

Address

P. O. Box 997 Airport Road, Digdaga, Ras Al Khaimah
Ras Al-Khaimah

Opening Hours

Monday 08:00 - 16:00
Tuesday 08:00 - 16:00
Wednesday 08:00 - 16:00
Thursday 08:00 - 16:00
Sunday 08:00 - 16:00

Telephone

+97172461461

Alerts

Be the first to know and let us send you an email when Julphar posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Julphar:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, was established in 1980 under the guidance of His Highness Sheikh Saqr Bin Mohammed Al Qasimi. The company employs 5,000 people and distributes a wide range of products to more than 50 countries on five continents across the globe.

Julphar’s business is centered on three core units – Diabetes Solutions, General Medicines, and its consumer division, Julphar Life. The company’s product portfolio of tablets, liquids, creams and injectables target major therapeutic segments including Family Care, Gastrology, Pain and Wound Management, Antibiotic, Cardiovascular and Metabolism.